Friends of Cancer Research
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$7,499,449
Contributions
93%
Investments
7%
Government Grants
0%
Fundraising Events
0%
Program Services
0%
Membership Dues
0%
Other
0%
Expenses in 2024
$5,771,194
Salaries & Benefits
52%
Other
26%
Fees to Service Providers
11%
Offices, Occupancy & IT
9%
Depreciation
1%
Grants
0%
Benefits to Members
0%
Advertising & Promotion
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$6,891,086
$6,949,510
+1%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$383,541
$549,939
+43%
Other
-$87,897
$0
-100%
Total Revenues
$7,186,730
$7,499,449
+4%
Expenses
2023
2024
Change
Grants
$0
$0
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$2,755,003
$3,021,050
+10%
Fees to Service Providers
$218,795
$642,516
+194%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$416,147
$521,748
+25%
Interest
$0
$0
-
Depreciation
$73,990
$69,416
-6%
Other
$1,781,072
$1,516,464
-15%
Total Expenses
$5,245,007
$5,771,194
+10%
Net income
2023
2024
Change
Net income
+$1,941,723
+$1,728,255
-11%
Functional Expenses
Summary
2023
2024
Change
Program
$3,394,650
$3,610,497
+6%
Admin
$1,126,391
$1,096,637
-3%
Fundraising
$723,966
$1,064,060
+47%
Total Expenses
$5,245,007
$5,771,194
+10%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)